The expression of METTL14 was significantly related to the overall survival of PCa patients and to tumor stage T. Additionally, we found that the expression level of METTL14 is associated with disease status (Complete regression/relapse) according to ICGC datasets. Here, METTL14 is linked to posterior cortical atrophy.